Status:
UNKNOWN
Bridging Therapy in Patients at High Risk for Stent Thrombosis Undergoing Surgery
Lead Sponsor:
Cedars-Sinai Medical Center
Conditions:
Bleeding
Thrombosis
Eligibility:
All Genders
18+ years
Brief Summary
Patients who have undergone placement of coronary stents require dual antiplatelet therapy with Plavix and aspirin to prevent the serious complication of in-stent thrombosis. Some of these patients wi...
Detailed Description
A. D/C clopidogrel 5 days prior to surgery B. Continue ASA (Increase dose to 325 mg until prohibitive bleeding risk) C. Check baseline IIb/IIIa and P2Y12 via the Verify Now device prior to initiatin...
Eligibility Criteria
Inclusion
- Patients' with BMS/DES on plavix prior to surgery who are in need of an elective procedures
Exclusion
- Patients' with BMS/DES on NOT plavix prior to surgery who are in need of an elective procedures
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2011
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00653601
Start Date
April 1 2008
End Date
April 1 2011
Last Update
September 4 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048